Skip to main content

Table 3 Distribution of MammaTyper® subtypes according to distant events

From: Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

   

no distant event

with distant event

N

%

N

%

N

%

Luminal A-like

195

60.6

185

94.9

10

5.1

Luminal B-like (HER2 negative)

119

37.0

103

86.6

16

13.4

Luminal B-like (HER2 positive)

2

0.6

2

100

0

0

Triple negative (ductal)

4

1.2

3

75.0

1

25.0

Not defined by St Gallen (ESR1−/PGR+)

2

0.6

1

50.0

1

50.0

Total

322

100

294

91.3

28

8.7